Alterations in mitochondrial function may have a central role in the pathogenesis of many neurodegenerative diseases. The study of mitochondrial dysfunction has typically focused on ATP generation, calcium homeostasis and the production of reactive oxygen species. However, there is a growing appreciation of the dynamic nature of mitochondria within cells. Mitochondria are highly motile organelles, and also constantly undergo fission and fusion. This raises the possibility that impairment of mitochondrial dynamics could contribute to the pathogenesis of neuronal injury. In this review we describe the mechanisms that govern mitochondrial movement, fission and fusion. The key proteins that are involved in mitochondrial fission and fusion have also been linked to some inherited neurological diseases, including autosomal dominant optic atrophy and Charcot-Marie-Tooth disease 2A. We will discuss the evidence that altered movement, fission and fusion are associated with impaired neuronal viability. There is a growing collection of literature that links impaired mitochondrial dynamics to a number of disease models. Additionally, the concept that the failure to deliver a functional mitochondrion to the appropriate site within a neuron could contribute to neuronal dysfunction provides an attractive framework for understanding the mechanisms underlying neurologic disease. However, it remains difficult to clearly establish that altered mitochondrial dynamics clearly represent a cause of neuronal dysfunction.
Introduction
Mitochondria play a vital role in the maintenance of the viability of neurons.
Clearly established functions include oxidative phosphorylation to supply ATP, as well as a critical role in calcium homeostasis [1] . It is widely appreciated that the interruption of mitochondrial function in neurons is typically associated with the initiation or amplification of neuronal injury [2] [3] [4] . Perhaps the most acute and dramatic example of mitochondrial failure would be in cerebral ischemia where the loss of oxygen and glucose, the key mitochondrial substrates, results in a rapid onset and severe injury to neurons. However, there are many other pathophysiological states that may be substantially influenced by mitochondrial dysfunction that are more subtle than acute bioenergetic collapse, and these injury mechanism may be manifested more slowly, in distinct compartments within neurons, or potentially even within a subset of mitochondria inside a single neuron.
From a cell biological standpoint, mitochondria within neurons are also very dynamic. It has been appreciated for many years that mitochondria may move rapidly and over relatively long distances in neurons (Reviewed by [5] ). More recently, it has become clear that mitochondria can undergo fission and fusion [6] [7] [8] . Moreover, changing the overall balance of fission and fusion can alter the size of discrete mitochondria from relatively short bodies to electrically contiguous, highly branched organelles that can stretch for hundreds of microns across a single cell [9] . Indeed, given the plasticity in the fission and fusion process a consideration of the number of mitochondria within a cell becomes meaningless, while the overall mitochondrial mass is a more relevant, if harder to measure, parameter.
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While mitochondrial dynamics in neurons are clear and easy to observe, the purpose of mitochondrial movement (or trafficking) or alterations in mitochondrial morphology is less obvious. One can readily develop a scheme that envisages the generation of new mitochondria in the proximity of the neuronal nucleus, the movement of mitochondria to sites of high ATP demand or calcium influx, the functioning of mitochondria at those sites for a finite period of time, and then the trafficking of old and dysfunctional mitochondria to a subcellular graveyard for their autophagic demise [10] .
These schemes are based on observations that essentially represent snapshots of mitochondrial function over relatively short periods of time (minutes to hours) in relation to the actual lifetime of a single organelle. While attractive and conceptually satisfying, this view of mitochondrial a life cycle lacks rigorous experimental demonstration. It is very difficult to establish where new mitochondria are made in neurons (but see [11] ), and there are no data that demonstrates an orderly progression of mitochondria from a site of biogenesis into the neuropil. While autophagy is a likely mechanism for mitochondrial disposal, the extent to which autophagy contributes to the overall turnover of mitochondrial mass in neurons remains unclear. Indeed, although the half life of brain mitochondria was estimated to be >15 days in studies performed nearly 50 years ago [12] remarkably little is known about the characteristics of mitochondrial turnover in neurons.
Nevertheless, even in the absence of a solid understanding of the physiological characteristics of mitochondrial dynamics, it is becoming clear that pathophysiologic events can profoundly impact mitochondrial trafficking and morphology. A variety of neurotoxic stimuli can halt mitochondrial movement, and separately there are factors that appear to trigger mitochondrial fragmentation that are also associated with neuronal 4 A C C E P T E D M A N U S C R I P T
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injury. From the kinds of observations that will be reviewed here, it can be hypothesized that interrupting normal mitochondrial dynamics causes neuronal injury.
In this review we will critically evaluate this hypothesis. We will review the physiological mechanisms and characteristics of both mitochondrial trafficking and mitochondrial morphology, and then describe the evidence showing that these processes are altered by neurotoxic stimuli. In some, but not all, cases there are established mechanisms that can account for the alterations in mitochondrial dynamics. A more challenging issue is the determination of whether altered mitochondrial dynamics actually drive neuropathology, or whether these changes are injury-related epiphenomena, and this will also be a focus of the review.
Mitochondrial Trafficking in Neurons
A. Mechanism and purposes of mitochondrial trafficking i. Trafficking machinery. There have been several excellent and recent reviews that provide detailed descriptions of the current understanding of the cellular machinery that is responsible for moving mitochondria within a variety of cell types including neurons [5, [13] [14] [15] . The brief summary of these mechanisms that follows is based on these reviews. Mitochondria in neuronal processes undergo saltatory anterograde and retrograde movement while retaining their identity as discrete organelles. Individual organelles are readily observed to start, stop, move over distances of tens or hundreds of microns at a velocity of several microns per second, and to change direction of movement. From the observation of mitochondrial movement in dendrites and axons in cultured neurons it is inferred that mitochondria could be undergoing purposeful
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movement from one destination in the cell to another, although practical limitations of imaging preclude tracking an individual organelle over more than a relatively modest distance, so the true origin and destination of any given mitochondrion remains an inference. The primary mechanism for long-distance movement of mitochondria requires microtubules. It is clear that anterograde axonal movement of mitochondria is generated by plus end-directed kinesins. Of the large number of kinesin family members, kinesin-1 and kinesin-3 appear to contribute to the movement of mitochondria. Retrograde axonal movement is likely to be mediated by dyneins. There are far fewer dynein heavy chains in vertebrates compared to the extensive family of kinesins, and cargo specificity is likely provided by a range of accessory proteins. Mitochondria can also move along the actin cytoskeleton. Several forms of myosin are found in neuronal processes, and myosin V may be the most likely form to be involved in mitochondrial attachment and movement along actin fibers.
ii. Docking and regulation of mitochondrial movement. Mitochondria alternate between saltatory movement and being stationary, and this is presumably a regulated process. The physiological control of this mitochondrial movement can, in principle, be accomplished in several ways. This includes the regulation of the attachment of mitochondria to the main motor proteins, and also includes docking or anchoring of mitochondria to static sites such as actin as well as other as yet unidentified cellular entities. Milton was recently identified as a motor adaptor protein that links kinesin motors to mitochondria in Drosophila axons to enable anterograde movement [16] .
While synapses form normally in Milton null flies they lack mitochondria in axons and
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A C C E P T E D M A N U S C R I P T [22] . It is perhaps to be anticipated that the collection of adaptor proteins that influence the anterograde and the retrograde movement of mitochondria will continue to grow, and with this growth will emerge a more complete appreciation of potential regulatory signals that control movement.
iii. Distribution of mitochondria in neurons. Until relatively recently, many of the detailed studies of mitochondrial distribution in neurons were essentially static evaluations performed on fixed tissues. These studies established that mitochondria are typically located at sites of high ATP demand, including synapses, growth cones, nodes of Ranvier, and myelination/demyelination interfaces (Reviewed in [5, 10] ). It is also clear that alterations in activity change the overall density of mitochondria, determined using cytochrome oxidase staining [23] . The use of fluorescence imaging approaches in cultured cells has allowed the real-time assessment of more dynamic aspects of mitochondrial distribution in live neurons. These studies have established the general characteristics of mitochondrial movement in both axons and dendrites of central and 7
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peripheral neurons [24] [ [24] [25] [26] [27] [28, 29] . These studies consistently demonstrate bidirectional movement of mitochondria, a subset of motile mitochondria while the majority remain stationary, and a finite frequency of apparent fission and fusion events (discussed in more detail below). There is relatively little information available about the interaction of individual mitochondria with specific locations within neurons. However, the potential for local signalling regulating trafficking was elegantly illustrated by Chada and Hollenbeck [30] who demonstrated that mobile mitochondria responded to the local application of nerve growth factor to an axon by becoming more likely to stop.
Mitochondria also respond to synaptic stimulation, where an increase in synaptic activity increases the probability that mitochondria will stop at a post-synaptic site [31] [32] [33] .
Conversely, inhibiting synaptic activity with tetrodotoxin results in an overall increase in mitochondrial motility, perhaps reflecting a reduction in calcium mediated docking [31] [32] [33] .
These studies clearly support the concept that some or all mitochondria are mobile within neurons, and that on a local basis and in response to acute stimulation, mitochondria can stop moving and dock at locations that are probably associated with an increased demand for ATP. It is harder to establish the nature of "long-distance" signals within neurons that direct the trafficking of mitochondria to specific, distant locations. reticulated mitochondria that are found in many cell types, including muscle [34] . Such structures have been reported in neuron dendrites, but not axons, using serial reconstructions from electron micrographs [35] . However, the studies cited above that track moving mitochondria do not report the presence of large reticulated mitochondria in either axons or dendrites of neurons in cultures (although the presence of such structures in cell bodies would go undetected). Alterations in the activity of fission or fusion proteins clearly has an impact on trafficking [31, 36] , but the nature of the interplay between the formation of mitochondrial networks and the dynamic distribution of mitochondria within neurons remains unclear.
B. Impairment of trafficking in neuronal injury
It is widely believed that impairment of the bioenergetic function of mitochondria contributes to neuronal injury. The developing thesis in this review is that the location of the mitochondrion in the neuron has an important influence on the ability of the organelle to meet the bioenergetic demands of the cell. A combination of these two concepts suggests that factors that impact the mobility of mitochondria could impair neuronal viability. In fact, accumulating literature suggests that there is an association between the action of some neurotoxins and the impairment of mitochondrial movement, although this impairment results from several quite distinct mechanisms. In this section we will review the neurotoxic mechanisms that inhibit trafficking, and then pose the question of whether impaired movement has been established to be causative of neuronal injury.
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i. Bioenergetic failure. Glutamate is a well-studied neurotoxin in primary neurons.
Acute application of high concentrations of glutamate activates calcium entry through Nmethyl-D-aspartate (NMDA) receptors, and this ultimately results in a delayed neuronal death that occurs 24-48 hrs later. It is clear that the large amounts of calcium that enter neurons through NMDA receptors must be taken up into mitochondria for injury to be expressed [37] [38] [39] . Additionally, this acute calcium load results in profound mitochondrial depolarization, which presumably limits ATP production [40, 41] . Using neurons that expressed a mitochondrially targeted yellow fluorescent protein, we found that NMDA receptor activation resulted in a rapid cessation of mitochondrial movement and also a decrease in mean mitochondrial length [42] , effects that were spatially limited to dendrites, rather than axons, where NMDA receptors are located [32] . The role of calcium will be discussed further below, but a series of experiments designed to manipulate the bioenergetic state of mitochondria independently of changes in intracellular calcium suggested that ATP production was key to support trafficking.
Thus, depolarizing mitochondria with the uncoupler FCCP, as well as inhibiting ATP synthesis with oligomycin both effectively impair movement [42, 43] . Interestingly, another electron transport chain inhibitor, nitric oxide, inhibits mitochondrial movement at similar concentrations to those that dissipate mitochondrial membrane potential [44, 45] . Collectively, these findings support the idea that mitochondrial ATP generation must be intact in order to support mitochondrial trafficking, perhaps because locally produced ATP serves as the fuel that drives the cellular motors that move mitochondria.
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ii. Ionic signals -Calcium and Zinc. The action of calcium following excitotoxic stimulation could be the result of several different phenomena. As described here, NMDA-mediated calcium overload certainly causes a bioenergetic impairment.
However, a number of studies have suggested that calcium regulates mitochondrial movement separately from a mechanism involving bioenergetic failure. For example, in cardiac myocytes, elevating cytosolic calcium to 1-2µM results in the complete arrest of mitochondrial movement along microtubules [46] . It is tempting to suggest that this mechanism is mediated by calcium binding to Miro, as is observed in drosophila neurons as described above [18, 20, 21, 47] . However, it is also clear that not all calcium signals impact mitochondrial movement. While glutamate and calcium ionophores arrest movement [20, 42] , stimuli that produce robust but smaller calcium changes, such as kainate or depolarization with potassium, do not [42, 48] . This contrasts with the suggestion that normal physiological calcium changes broadly regulate motility in neurons in culture [18, 20, 21, 47] .
Zinc is an important trace metal that has been implicated in a number of neurodegenerative disease states [49] . Zinc can substitute for calcium in many transport processes and is transported and putatively released by mitochondria [50] . Elevated intracellular zinc is toxic to neurons in primary culture at relatively low concentrations.
Studies that illustrated the minimally effective toxic exposure to intracellular zinc also showed that zinc blocked mitochondrial movement in primary neurons [51] . This effect was independent of any clear impact on the bioenergetic function of neurons.
Interestingly, the effect of zinc on mitochondrial movement and on neurotoxicity was blocked by wortmannin, which affords a transient inhibition of PI-3 kinase activity at the 11
concentrations used in this study [51] . These findings provide a parallel to the conclusions of Chada and Hollenbeck [30] who reported that NGF promoted mitochondrial docking which may also be associated with PI-3 kinase activation. It should also be noted that zinc clearly produces other effects on mitochondria at slightly higher concentrations than those that activate PI-3 kinase. These effects include mitochondrial depolarization, and are associated with a form of injury that is not blocked by wortmannin [51] .
iii. Disease-causing proteins and mitochondrial trafficking. There is a growing body of evidence that proteins associated with neurodegenerative disease can impact axonal transport of organelles in general and mitochondria in particular. A conceptually simple mechanism by which this might occur is through the formation of aggregates in neuronal processes that block transport. One example of this is provided by neurons expressing expanded polyglutamine forms of huntingtin, the protein responsible for
Huntington's disease. In these neurons aggregates were invariably associated with mitochondria, and regions of the neurite around the aggregate displayed less mitochondrial movement [52] . There are a number of reports that describe other interactions with mitochondrial trafficking, including decreased mitochondrial velocity [53] , and an impairment of the association of mitochondria with microtubule-based transport proteins [54] . It is not clear that the impairment of trafficking is specific to mitochondria in mtHtt expressing cells, as vesicular trafficking is also impacted [55, 56] .
However, the effect of slowing mitochondrial delivery to sites of ATP demand distal to an aggregate-blocked process provides a conceptually appealing mechanism to account A C C E P T E D M A N U S C R I P T
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for the slowly developing loss of striatal neuron function that is associated with this disease.
Unlike Huntington's disease, amyotrophic lateral sclerosis is largely a sporadic disease. However, the disease has been effectively modeled in mice by the overexpression of mutant forms of copper-zinc superoxide dismutase (mtSOD1), which was identified in the less common familial forms of the disease. In neurons derived from mtSOD1 expressing mice, profound mitochondrial defects are observed to coincide with the appearance of motor neuron pathology [57] . In addition, there is evidence for decreased entry of mitochondria into axons beyond the initial segment as well as decreased retrograde transport of mitochondria in the axons of motor neurons [58, 59] from studies of mtSOD1 mice. More recently, direct observation of mitochondrial trafficking in motor neurons has shown that trafficking is impaired by mtSOD1 [60, 61] .
The mechanism of impaired transport is not entirely clear. Mutant SOD1 is found associated with mitochondria, and it is possible that this disrupts the interaction of mitochondria with motor proteins or their adaptors. Like mtHtt, mtSOD1 also aggregates, allowing for the possibility of a physical obstruction. However, it is also clear that metabolic dysfunction could be a key early event, so that disrupting the delivery of ATP to the motors would be involved in the cessation of movement [61] .
The microtubule associated protein tau when hyperphosphorylated forms neurofibrillary tangles that are one of the hallmarks of Alzheimer's disease [62] . Tau can also have an important impact on mitochondrial trafficking. Tau interferes with the attachment of cargoes to kinesin-based motors, so that tau overexpression results in the accumulation of mitochondria near the minus end of microtubules in the center of the cell
13
A C C E P T E D M A N U S C R I P T ACCEPTED MANUSCRIPT [63] . In primary neurons, tau overexpression results in the depletion of mitochondria from neurites [64] . Phosphorylation of tau results in its dissociation from microtubules and their subsequent destabilization [65] which would interrupt the delivery of mitochondria to key cellular sites. Both amyloid precursor protein (APP) and apolipoprotein E4 can interact with mitochondria and impair bioenergetic function [66, 67] (Reviewed by [4] ), and these could result in the impairment of mitochondrial trafficking. It remains a challenge to attribute the key pathology in Alzheimer's disease to a single pathogenic mechanism, but impairing the delivery of mitochondria to presynaptic sites in axons and the subsequent loss of synaptic activity again provides an appealing mechanism to account for a disease characterized by the progressive loss of synaptic connections.
C. Mitochondrial Trafficking Defects in Neurodegeneration: Cause or Effect?
This section has identified associations between a number of mechanisms associated with neurodegeneration where there is also evidence for impairment of mitochondrial trafficking. Both acute and chronic neurodegenerative disease states may feature trafficking disruptions, and it seems self evident that if mitochondria are not delivered to the right place at the right time the viability of the neuron will be negatively affected. On the other hand, it is clear that some of the mechanisms that impact trafficking could very readily be secondary to the main pathogenic event. For example, if the primary pathogenic event involves bioenergetic disruption, then it is very likely that mitochondria will ultimately stop moving. However, it would be difficult to conclude that the cessation of trafficking was the cause of the neuronal injury. Many of the 14
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examples cited here, such as glutamate excitotoxicity, mtHtt, mtSOD1 and ApoE4 mediated injury have also been associated with bioenergetic dysfunction, so it remains to be established exactly how the alteration in trafficking contributes to the injury process.
Indeed, at this point it is difficult to unequivocally attribute any neurodegenerative disease state to impaired delivery of mitochondria as a primary cause. With a greater appreciation of the specific mechanisms that transport mitochondria in neurons it may be possible to design an approach that interrupts mitochondrial trafficking selectively, while leaving other transport processes intact, to determine whether the trafficking defect is actually toxic. Even then, toxicity may still only be evident when the trafficking defect is coupled with the imposition of a cellular stressor, which additionally challenges the design of the definitive experiment.
Mitochondrial Morphology and Neuronal Injury
In addition to the dynamic movement of mitochondria within neurons, it is also clear that mitochondria can change shape. The typical morphology of a mitochondrion observed in an axon or dendrite is a filamentous structure that ranges from a few microns to several tens of microns long. As described in this section, it has become clear that the morphology and interconnectedness of mitochondria is dynamically controlled by a series of proteins, and also that mitochondria routinely undergo fission and fusion for purposes that are not yet entirely clear [6, 7] . In addition, there is an emerging view that morphology of mitochondria may change in association with injury. In this section we 15 M A N U S C R I P T
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will review the mechanisms controlling mitochondrial morphology, and then critically evaluate the proposal that altered morphology drives neuronal viability.
A Regulating mitochondrial morphology in neurons i. Fission proteins
The Dynamin-Related Protein 1 (Drp1) gene from Caenorhabditis elegans [68] was one of the first genes shown to be involved in mediating mitochondrial fission. Overexpression of Drp1 results in fragmented mitochondria in C. elegans [68] and in mammalian neurons [69] . Smirinova and her colleagues reported that transfection of COS-7 cells with a dominant-negative Drp1 results in more interconnected mitochondria [70] , and that Drp1 is localized to mitochondrial scission points [71] , further supporting the assertion that Drp1 mediates mitochondrial fission. These effects have also been observed in cortical neurons; Uo and colleagues [72] reported that shRNA-mediated reduction of endogenous Drp1 or expression of a dominant negative Drp1 results in elongated mitochondria.
Recently, a mechanism of regulation of Drp1-mediated fission has been reported which links high calcium levels associated with excitotoxicity and mitochondrial fission.
Elevated calcium may activate calcineurin which in turn dephosphorylates Drp1. Drp1 is then translocated to mitochondrial where it induces fission [73] [74] [75] . The dynein/dynactin complex [76] and actin [77] have also been reported to play a role in regulating translocation of Drp1 to mitochondria, although the role of these elements has yet to be investigated in neurons. The activity of Drp1 has also been reported to be modulated by sumoylation [78] [79] and mitochondrial membrane potential [77] .
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ii. Fusion Proteins. The first protein involved in mitochondrial fusion was identified by
Hales and Fuller [80] in the drosophila "fuzzy onions" mutant. During drosophila spermatogenesis, this protein (fzo) was shown to mediate the fusion of mitochondria.
Two human homologues, Mitofusin 1 (Mfn1) and Mitofusin 2 (Mfn2) were subsequently identified [81] . Over-expression of Mfn2 in COS-7 cells caused normally punctate mitochondria to become more elongated, an effect that was more pronounced when cells were co-transfected with a dominant negative form of Drp1 (Drp1-K38A) [81] . These results suggest that mitochondrial morphology is the result of a balance between the opposing effects of Drp1 and the mitofusins. More recently, it has been shown that Mfn1
and Mfn2 may act together in a heterooligomeric complex to control fusion [82] .
Another highly studied gene proposed to play a role in mitochondrial dynamics is Optic Atrophy Protein 1 (OPA1). Loss of OPA1 has been associated with compromise of the inner mitochondrial membrane, cytochrome C release and subsequent apoptosis. [83] The OPA1 gene has eight alternative splice variants [84] and complex posttranslational processing including proteolytic cleavage [85, 86] . Interestingly, the activity of OPA1 may be modulated by this cleavage, a process that has been linked to the bioenergetic state of the cell; dissipation of the mitochondrial membrane potential, the driving force for ATP production, has been reported to induce proteolytic processing of OPA1 and subsequent mitochondrial fragmentation [86] [87] [88] . Moreover, altered OPA1 processing has been linked to ATP depletion [89] In mammalian cells the fusion-inducing proteins described above are required, and operate in concert to fuse two mitochondria. In a recent paper Song et al [90] A C C E P T E D M A N U S C R I P T (CMT2A) [93] . CMT2A is a peripheral neuropathy which targets the axons of sensory and motor neurons. Degeneration of these peripheral neurons results in muscle weakness, primarily in the lower limbs [94] . In addition to deficits in mitochondrial fusion, impairment of mitochondrial transport has also been reported as a consequence of expression of mutant Mfn2 [95] . This may in part explain why long peripheral nerves are targeted in this disease. [95] .
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Recently Parkinson's and Alzheimer's diseases have also been associated with changes in mitochondrial morphology, although in contrast to the above disorders, they are usually associated with advanced age. Loss of function mutations or deletions of the Parkinson's associated genes PTEN-induced kinase 1 (pink1) and parkin have been shown to be associated with mitochondrial fragmentation in several mammalian cell expression systems [96] [97] [98] [99] . Studies in Drosophila have shown that loss of function mutations or deletions of Pink1 and parkin impact upon mitochondrial dynamics [100, 101] . The studies in Drosophila are a little harder to interpret, because they reflect Pink1/ parkin modulation of mitochondrial morphology driven by fission or fusion protein expression, but the conclusion appears to be that the Parkinson's proteins proteins promote fission in the fly. Observing opposite effects of Pink1 and parkin depending on expression system begs the question of whether these effects reflect a direct modulation of fission, or whether the effects are secondary to an alteration in mitochondrial function [102] . Fibroblasts isolated from Alzheimer's exhibit significantly decreased Drp1 and exhibited elongated mitochondria, suggesting a role for alterations in mitochondrial dynamics in the pathogenic mechanism [103] . Additional studies also revealed evidence for amyloid β-induced mitochondrial fragmentation in neuronal cells and in Alzheimer's brain tissue [104, 105] . The toxic effect of Aβ oligomers on mitochondria is also correlated with alterations in spine density and synaptic connectivity. As noted above, hyperphosphorylation of tau can potentially disrupt mitochondrial trafficking, but based on current knowledge of Alzheimer's disease pathophysiology, it could be argued that Aβ-mediated disruptions are upstream of altered tau function.
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There are several notable features that are shared by these diseases. Firstly, even though the mutated proteins are found throughout the body, the diseases are associated with relatively specific neuronal pathologies, which suggest that there is some aspect of neuronal physiology that is especially vulnerable to alterations in fission and fusion.
Secondly, it is notable that neurons can function ostensibly normally for years or even decades before the effects of these mutations become manifest. This suggests that the impact of altered fission and fusion is relatively subtle, and perhaps only results in neuronal injury in the presence of an additional stressor, or as the result of an accumulation of maladaptive events.
ii. Acute morphological changes -fission, permeability transition or rounding?
In our study examining the effects of excitotoxic glutamate on mitochondrial motility and morphology in cortical neurons, we observed a cessation of mitochondrial movement and significant reductions in mitochondrial length [42] . While the morphological changes we observed resulted in an overall more fragmented appearance of mitochondria, we observed that the majority of mitochondria underwent a morphological change from being thread-like to punctate, as measured by an increase in the "roundness" of individual mitochondria. Others have reported similar "rod-like-torounded" morphology changes of mitochondria in neurons [106] [107] and astrocytes [108] . The mechanism underlying rounding of mitochondria is not entirely clear. Under some circumstances mitochondria lose the integrity of the inner membrane in a process termed mitochondrial permeability transition. This is typically characterized by swelling of isolated mitochondria, and could be reflected by rounding of filamentous mitochondria 20
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in neurons [106] [107] . It is also clear that there are substantial structural changes in dendrites including beading [42] which could impact mitochondrial shape.
In examining mitochondrial morphology changes we were cautious in classifying what we observed as fragmentation, as individual mitochondria could be clusters/chains of individual mitochondria that pull apart. Similar microscopy limitations plague quantification of mitochondrial fusion, particularly in neurons where mitochondria move along the restrictive pipelines of axons and dendrites, passing above or below each other without fusing [109] . However, newly developed techniques employing photoactivatable GFP targeted to mitochondria allows for quantitative assessment of aggregate fusion rates [110] and direct visualization (and hence quantification) of both fission and fusion events [109] .
C. What is the functional consequence of morphological change?
As described in the examples above, mutations in fission/fusion genes can result in neurodegeneration. It has been suggested that the unique energy requirements of neurons may in part explain why diseases associated with these mitochondrial perturbations are selective for neurons [111] . However, exactly how a deficit in fusion/fission causes neurodegeneration remains to be determined. Therefore in this final section we shall review the evidence linking changes in morphology to mitochondrial function and injury. [112] . Conversely, over expression of Mfn2 in muscle cells has been shown to result in mitochondrial fusion and an increase in mitochondrial metabolism [113] .
ii) Impact on Cellular viability. The link between morphological changes induced by expression of the mitochondrial-shaping genes described above and cell survival was first provided by Richard Youle and his colleagues [114] . They and others [115] observed that following apoptotic stimuli, mitochondria undergo a transformation from reticular to punctuate morphology. Youle and his colleagues also reported that following exposure to apoptotic stimuli, over-expression of the dominant negative Drp1 mutant (Drp1-K38A), results in maintenance of reticular mitochondria, prevents loss of mitochondrial membrane potential, prevents release of cytochrome c and blocks cell death [114] . This study therefore provides evidence that mitochondrial fission may comprise a step in apoptotic cell death. In addition, it has been subsequently demonstrated in various cell types, that fragmenting mitochondria predisposes cells to injury [69] , whereas fusing mitochondria can be protective [116, 117] . Interestingly, deleting Drp1 alters cytochrome c release from mitochondria, but apparently does not impact frank permeabilization of the mitochondrial outer membrane that is associated with the release
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of apoptosis-triggering proteins [118] , again consistent with the idea that fission may be a modulator of apoptotic cell injury.
While there is strong evidence that associates changes in mitochondrial morphology with neuronal injury, and equally strong evidence that altering mitochondrial morphology can predispose or protect cells in injury paradigms, there is surprisingly little evidence to support a causative role for(protein expression) induced mitochondrial morphology changes in injury. ie fragmenting mitochondria does not necessarily result in neuronal injury. It has been reported that expression of Drp1 can result in neuronal cell death [69] . However in this study, the authors report that a significant number of neurons displayed mitochondrial fragmentation but did not die and conclude that mitochondria fission is a required element in neuronal death but not sufficient to cause injury on its own. In our hands, over expressing Drp1 in cortical neurons results in mitochondrial fragmentation, but does not have a significant impact upon neuronal health [119] . Others have also shown that inducing fission through over expression OPA1 has no significant adverse effects on cell viability, respiration rates or mitochondrial membrane potential [112] . While fragmentation of mitochondria has been associated with neuronal injury, there is little direct evidence of mitochondria fragmentation initiating/causing injury. This argues that morphological changes may comprise a step in injury mechanisms, but in some cases the remodeling of mitochondria may in fact reflect a response to injury.
Conclusions
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It should be apparent that there is a rich and growing literature that illustrates the interplay between mitochondrial dynamics, morphology and neuronal function.
Moreover, much of the emerging information suggests that these alterations occur in the proximity of neuronal injury. Based on observations made in several inherited diseases, such as CMT2A, it is clear that there is a cause and effect relationship between mutations in genes controlling mitochondrial fission and fusion such that impaired fusion or excessive fission decreases neuronal viability. It is tempting to extend this conclusion to other disease states where altered mitochondrial morphology or trafficking is observed in response to neurotoxins, for example, because the phenomena of altered morphology and impaired trafficking appear similar. However, unlike the rare genetic diseases, the data at this time does not conclusively establish that the mitochondrial changes represent a critical step in neuronal injury rather than a closely-associated epiphenomenon.
There has been remarkable progress in the appreciation of the mechanisms that are responsible for the movement of mitochondria, the specification of mitochondria as a cargo for cellular motors, and some of the factors that control movement and docking.
Also, with the development of imaging technologies, it has become possible to more clearly study fission and fusion events in live cells. Collectively, these studies reinforce the notion that mitochondria are highly dynamic organelles. Given the unique architecture of neurons, the appearance and potential impact of these dynamics is amplified. Mitochondria move bidirectionally in neurons, and appear to dock specifically at sites with increased ATP demands. They also appear to undergo a frequent and ongoing process of fusion and fission, the purpose of which remains incompletely understood. However, these events are readily observable in live cells and in real time.
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It is also clear that mitochondrial dynamics are impacted by a number of different cellular changes associated with disease states. As noted above, mutations in fission and fusion protein genes are associated with neurological diseases in humans, and this perhaps provides the most direct evidence that alterations in fission or fusion can cause disease. However, there are numerous additional examples where pathogens stop mitochondrial movement (e.g. glutamate or zinc), trap mitochondria around aggregated proteins (e.g. mtHtt), or cause rounding or fragmentation of normally filamentous mitochondria (e.g. calcium overload or Drp1 overexpression). In general, this leads to the impression that circumstances in neurons associated with immobile or fragmented mitochondria are associated with decreased neuronal viability (although there are clearly exceptions to this view), and it is tempting to propose that it is the dramatic changes in these dynamics that causes pathology. This, however, remains hard to convincingly establish with tools currently available, so that for most of these phenomena we cannot establish whether immobilization of mitochondria, for example, causes the death of the neuron, or whether this is just a marker for the primary pathogenic event. Additionally, while tracking fission, fusion or trafficking events acutely is highly feasible, it remains difficult to monitor slower changes in mitochondrial distribution or function that probably would be a better representation of events that contribute to chronic neurodegenerative disease. The evolution of molecular tools that allow the inducible alteration of specific mitochondrial parameters may represent the most fruitful way to address the question of cause and effect.
There remain significant gaps in understanding. There is very limited information available to understand how mitochondrial biogenesis contributes to the overall dynamics
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of mitochondria in neurons, even though it is clear that mitochondrial expression is closely tied to neuronal activity. It is also not clear how we should view the overall turnover of mitochondria in neurons: are mitochondria born, function for a finite time and are then cleared by autophagy, or is it more appropriate to conceive of an organelle whose components are constantly renewed and repaired by on-going protein synthesis and DNA replication aided by the dilutive process of fusion and fission? And finally, can we see these events in neurons in their native environment in animals? The gaps in understanding are significant, but current knowledge suggests that this remains a fertile area for further study.
